Magazine Article | October 10, 2017

Can David Hung Lead Axovant To Alzheimer's Success?

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

“I couldn’t get a job in biotech,” says David Hung, M.D.

Having completed medical school, a residency, two basic science research fellowships, and three clinical fellowships, Hung had spent his entire career in academia. So why was he even looking to leave? “I was in the third year of a fellowship when a patient of mine, a 28-year-old woman, died of metastatic breast cancer,” he explains. “This had a profound impact on me, and I decided right then and there I wasn’t going to spend the rest of my life practicing as a clinical oncologist armed with only the currently available technologies that couldn’t prevent the death of someone so young.”

THIS CONTENT IS EXCLUSIVELY FOR LIFE SCIENCE LEADER PAID SUBSCRIBERS.
To continue reading this story and receive uninterrupted access to LSL Online and its monthly magazine subscribe to Life Science Leader today!
Already a subscriber? Log in now.